Increased expression of cyclooxygenase-2 and nitric:: oxide synthase-2 in human prostate cancer

被引:39
作者
Uotila, P
Valve, E
Martikainen, P
Nevalainen, M
Nurmi, M
Härkönen, P
机构
[1] Univ Turku, Dept Physiol, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Clin Physiol, FIN-20520 Turku, Finland
[3] Univ Turku, Dept Anat, FIN-20520 Turku, Finland
[4] Tampere Univ Hosp, Dept Pathol, Tampere 33521, Finland
[5] Univ Turku, Dept Surg, Turku 20521, Finland
来源
UROLOGICAL RESEARCH | 2001年 / 29卷 / 01期
关键词
prostate cancer; prostatic intraepithelial neoplasia cyclooxygenase-1; cyclooxygenase-2; nitric oxide synthase-2;
D O I
10.1007/s002400000148
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase-2 (NOS-2) each have an important role in angiogenesis. The expression of these genes was investigated in human prostate cancer by immunohistochemistry, the expression of COX-1 and COX-2 being confirmed by mRNA analysis. Prostate cancer specimens from 12 patients were compared to control prostates from 13 patients operated on for bladder carcinoma. The intensity of COX-2 and NOS-2 immunostaining was significantly stronger in prostate cancer cells than in the non-malignant glandular epithelium of the control prostates. COX-2 and NOS-2 were clearly also expressed in the lesions of prostatic intraepithelial neoplasia (PIN) in control prostates. COX-2 was detected in the muscle fibres of the hyperplastic stroma of some control prostates. No significant difference was detected in COX-1 expression between control and cancer prostates. These results indicate that the expression of COX-2 and NOS-2 is elevated in prostatic adenocarcinoma and in PIN.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 28 条
[1]   THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE [J].
BERRY, SJ ;
COFFEY, DS ;
WALSH, PC ;
EWING, LL .
JOURNAL OF UROLOGY, 1984, 132 (03) :474-479
[2]  
BOSTWICK DG, 1995, CANCER-AM CANCER SOC, V75, P1823, DOI 10.1002/1097-0142(19950401)75:7+<1823::AID-CNCR2820751612>3.0.CO
[3]  
2-7
[4]   Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer [J].
Gallo, O ;
Masini, E ;
Morbidelli, L ;
Franchi, A ;
Fini-Storchi, I ;
Vergari, WA ;
Ziche, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (08) :587-596
[5]   Is there a role for nitric oxide in tumor angiogenesis? [J].
García-Cardeña, G ;
Folkman, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (08) :560-561
[6]  
Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO
[7]  
2-G
[8]   Inhibition of nitric oxide synthase as a potential therapeutic target [J].
Hobbs, AJ ;
Higgs, A ;
Moncada, S .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :191-220
[9]   The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 [J].
Hsu, AL ;
Ching, TT ;
Wang, DS ;
Song, XQ ;
Rangnekar, VM ;
Chen, CS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :11397-11403
[10]  
Isoherranen K, 1999, BRIT J DERMATOL, V140, P1017